AU2005292655A1 - Non-absorbent and absorbent articles for inhibiting the production of exoproteins - Google Patents

Non-absorbent and absorbent articles for inhibiting the production of exoproteins Download PDF

Info

Publication number: AU2005292655A1
Authority: AU; Australia
Prior art keywords: absorbent; group; tampon; set forth; benzyl
Prior art date: 2004-09-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

AU2005292655A

Other languages

English (en)

Inventor

Daniel J. Devine

Kristin A. Goerg-Wood

Rae Ellen Syverson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Kimberly Clark Worldwide Inc

Original Assignee

Kimberly Clark Worldwide Inc

Kimberly Clark Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-30

Filing date

2005-08-10

Publication date

2006-04-13

2004-09-30 Priority claimed from US10/955,821 external-priority patent/US20060067990A1/en

2004-09-30 Priority claimed from US10/955,858 external-priority patent/US20060067991A1/en

2005-08-10 Application filed by Kimberly Clark Worldwide Inc, Kimberly Clark Corp filed Critical Kimberly Clark Worldwide Inc

2006-04-13 Publication of AU2005292655A1 publication Critical patent/AU2005292655A1/en

Status Withdrawn legal-status Critical Current

Links

239000002250 absorbent Substances 0.000 title claims description 171
230000002745 absorbent Effects 0.000 title claims description 169
238000004519 manufacturing process Methods 0.000 title claims description 73
230000002401 inhibitory effect Effects 0.000 title claims description 24
150000001875 compounds Chemical class 0.000 claims description 207
239000002243 precursor Substances 0.000 claims description 117
239000000463 material Substances 0.000 claims description 61
210000001215 vagina Anatomy 0.000 claims description 57
241000192125 Firmicutes Species 0.000 claims description 36
235000001014 amino acid Nutrition 0.000 claims description 36
150000001413 amino acids Chemical class 0.000 claims description 36
239000000203 mixture Substances 0.000 claims description 29
239000000758 substrate Substances 0.000 claims description 29
NNSTUHMKYNCMHO-UHFFFAOYSA-N 2-[2-(2-tetradecoxyethoxy)ethoxy]ethyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOCCOCCOCCOC(=O)CCCCCCCCCCCCC NNSTUHMKYNCMHO-UHFFFAOYSA-N 0.000 claims description 28
238000003780 insertion Methods 0.000 claims description 27
230000037431 insertion Effects 0.000 claims description 27
238000009472 formulation Methods 0.000 claims description 20
XTXCFTMJPRXBBC-UHFFFAOYSA-N methyl 4,4-dimethyl-3-oxopentanoate Chemical compound COC(=O)CC(=O)C(C)(C)C XTXCFTMJPRXBBC-UHFFFAOYSA-N 0.000 claims description 18
239000004094 surface-active agent Substances 0.000 claims description 18
238000006460 hydrolysis reaction Methods 0.000 claims description 17
230000007062 hydrolysis Effects 0.000 claims description 16
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 15
125000001183 hydrocarbyl group Chemical group 0.000 claims description 15
125000004432 carbon atom Chemical group C* 0.000 claims description 14
229910052739 hydrogen Inorganic materials 0.000 claims description 14
SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 claims description 13
239000003112 inhibitor Substances 0.000 claims description 13
CGNOCUSLPSCMLL-UHFFFAOYSA-N 3-o-benzyl 1-o-ethyl propanedioate Chemical compound CCOC(=O)CC(=O)OCC1=CC=CC=C1 CGNOCUSLPSCMLL-UHFFFAOYSA-N 0.000 claims description 12
125000005842 heteroatom Chemical group 0.000 claims description 12
229920006395 saturated elastomer Polymers 0.000 claims description 12
QNRYOQRUGRVBRL-UHFFFAOYSA-N benzyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC1=CC=CC=C1 QNRYOQRUGRVBRL-UHFFFAOYSA-N 0.000 claims description 11
206010021639 Incontinence Diseases 0.000 claims description 10
150000002148 esters Chemical class 0.000 claims description 9
125000003118 aryl group Chemical group 0.000 claims description 8
POLGZPYHEPOBFG-UHFFFAOYSA-N 2-benzamido-4-methylpentanoic acid Chemical compound CC(C)CC(C(O)=O)NC(=O)C1=CC=CC=C1 POLGZPYHEPOBFG-UHFFFAOYSA-N 0.000 claims description 7
ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 claims description 7
125000004494 ethyl ester group Chemical group 0.000 claims description 7
150000004702 methyl esters Chemical class 0.000 claims description 7
239000003433 contraceptive agent Substances 0.000 claims description 6
230000002254 contraceptive effect Effects 0.000 claims description 6
ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 claims description 5
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 5
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 5
229920002884 Laureth 4 Polymers 0.000 claims description 5
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 5
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 5
229940059082 douche Drugs 0.000 claims description 5
229940061515 laureth-4 Drugs 0.000 claims description 5
239000004474 valine Substances 0.000 claims description 5
MIYQNOPLWKCHED-UHFFFAOYSA-N 2-benzamido-3-methylbutanoic acid Chemical compound CC(C)C(C(O)=O)NC(=O)C1=CC=CC=C1 MIYQNOPLWKCHED-UHFFFAOYSA-N 0.000 claims description 4
230000004888 barrier function Effects 0.000 claims description 4
229910052760 oxygen Inorganic materials 0.000 claims description 4
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 3
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 3
235000018417 cysteine Nutrition 0.000 claims description 3
ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 claims 4
SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 claims 4
GGPOVLCFVFOVDF-UHFFFAOYSA-N 2-phenoxyethyl 4-hydroxybenzoate Chemical compound C1=CC(O)=CC=C1C(=O)OCCOC1=CC=CC=C1 GGPOVLCFVFOVDF-UHFFFAOYSA-N 0.000 claims 2
MOZDKDIOPSPTBH-UHFFFAOYSA-N Benzyl parahydroxybenzoate Chemical compound C1=CC(O)=CC=C1C(=O)OCC1=CC=CC=C1 MOZDKDIOPSPTBH-UHFFFAOYSA-N 0.000 claims 2
229960002903 benzyl benzoate Drugs 0.000 claims 2
229940034794 benzylparaben Drugs 0.000 claims 2
229940078469 dl- cysteine Drugs 0.000 claims 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 78
101000794214 Staphylococcus aureus Toxic shock syndrome toxin-1 Proteins 0.000 description 53
238000012360 testing method Methods 0.000 description 49
239000000047 product Substances 0.000 description 42
-1 aliphatic alcohols Chemical class 0.000 description 32
235000019445 benzyl alcohol Nutrition 0.000 description 26
241000894006 Bacteria Species 0.000 description 23
239000003053 toxin Substances 0.000 description 21
231100000765 toxin Toxicity 0.000 description 21
108700012359 toxins Proteins 0.000 description 21
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 20
230000000694 effects Effects 0.000 description 20
239000001963 growth medium Substances 0.000 description 18
BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 18
230000005764 inhibitory process Effects 0.000 description 15
238000000034 method Methods 0.000 description 15
239000012530 fluid Substances 0.000 description 14
239000000126 substance Substances 0.000 description 14
125000000217 alkyl group Chemical group 0.000 description 13
244000005700 microbiome Species 0.000 description 13
102000004190 Enzymes Human genes 0.000 description 12
108090000790 Enzymes Proteins 0.000 description 12
230000002829 reductive effect Effects 0.000 description 12
241000283973 Oryctolagus cuniculus Species 0.000 description 11
239000005711 Benzoic acid Substances 0.000 description 10
235000010233 benzoic acid Nutrition 0.000 description 10
239000000835 fiber Substances 0.000 description 10
239000000243 solution Substances 0.000 description 10
238000004458 analytical method Methods 0.000 description 9
239000012531 culture fluid Substances 0.000 description 8
238000011534 incubation Methods 0.000 description 8
239000011087 paperboard Substances 0.000 description 8
229930000044 secondary metabolite Natural products 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
206010040070 Septic Shock Diseases 0.000 description 7
206010044248 Toxic shock syndrome Diseases 0.000 description 7
231100000650 Toxic shock syndrome Toxicity 0.000 description 7
239000000654 additive Substances 0.000 description 7
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 7
238000000576 coating method Methods 0.000 description 7
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 7
239000002953 phosphate buffered saline Substances 0.000 description 7
239000000523 sample Substances 0.000 description 7
238000003860 storage Methods 0.000 description 7
108091003079 Bovine Serum Albumin Proteins 0.000 description 6
108010001336 Horseradish Peroxidase Proteins 0.000 description 6
239000004698 Polyethylene Substances 0.000 description 6
239000004793 Polystyrene Substances 0.000 description 6
230000009286 beneficial effect Effects 0.000 description 6
230000015556 catabolic process Effects 0.000 description 6
238000010790 dilution Methods 0.000 description 6
239000012895 dilution Substances 0.000 description 6
239000000123 paper Substances 0.000 description 6
229920000573 polyethylene Polymers 0.000 description 6
229920002223 polystyrene Polymers 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
241000894007 species Species 0.000 description 6
108700023418 Amidases Proteins 0.000 description 5
108090000371 Esterases Proteins 0.000 description 5
241000186660 Lactobacillus Species 0.000 description 5
238000010521 absorption reaction Methods 0.000 description 5
102000005922 amidase Human genes 0.000 description 5
238000003556 assay Methods 0.000 description 5
239000003795 chemical substances by application Substances 0.000 description 5
239000011248 coating agent Substances 0.000 description 5
125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
239000000314 lubricant Substances 0.000 description 5
230000002175 menstrual effect Effects 0.000 description 5
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
239000004743 Polypropylene Substances 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
229940098773 bovine serum albumin Drugs 0.000 description 4
239000000872 buffer Substances 0.000 description 4
239000011111 cardboard Substances 0.000 description 4
230000001332 colony forming effect Effects 0.000 description 4
230000003247 decreasing effect Effects 0.000 description 4
238000005516 engineering process Methods 0.000 description 4
239000012091 fetal bovine serum Substances 0.000 description 4
239000002054 inoculum Substances 0.000 description 4
239000002674 ointment Substances 0.000 description 4
229920003023 plastic Polymers 0.000 description 4
239000004033 plastic Substances 0.000 description 4
229920001155 polypropylene Polymers 0.000 description 4
239000011257 shell material Substances 0.000 description 4
229920001169 thermoplastic Polymers 0.000 description 4
239000004416 thermosoftening plastic Substances 0.000 description 4
210000001519 tissue Anatomy 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
229920000742 Cotton Polymers 0.000 description 3
JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
229920001213 Polysorbate 20 Polymers 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
229920000297 Rayon Polymers 0.000 description 3
239000000853 adhesive Substances 0.000 description 3
230000001070 adhesive effect Effects 0.000 description 3
150000001298 alcohols Chemical class 0.000 description 3
230000000844 anti-bacterial effect Effects 0.000 description 3
229940088710 antibiotic agent Drugs 0.000 description 3
150000001491 aromatic compounds Chemical class 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
239000012876 carrier material Substances 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
201000010099 disease Diseases 0.000 description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
239000012153 distilled water Substances 0.000 description 3
229920001971 elastomer Polymers 0.000 description 3
238000005538 encapsulation Methods 0.000 description 3
239000001257 hydrogen Substances 0.000 description 3
210000004914 menses Anatomy 0.000 description 3
230000003821 menstrual periods Effects 0.000 description 3
230000000813 microbial effect Effects 0.000 description 3
150000002894 organic compounds Chemical class 0.000 description 3
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
239000011148 porous material Substances 0.000 description 3
239000002964 rayon Substances 0.000 description 3
239000005060 rubber Substances 0.000 description 3
210000002966 serum Anatomy 0.000 description 3
239000011734 sodium Substances 0.000 description 3
239000007787 solid Substances 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
LZMSXDHGHZKXJD-VJANTYMQSA-N trypanothione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H]1CSSC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(=O)NCCCNCCCCNC(=O)CNC1=O LZMSXDHGHZKXJD-VJANTYMQSA-N 0.000 description 3
FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
239000001856 Ethyl cellulose Substances 0.000 description 2
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
239000004812 Fluorinated ethylene propylene Substances 0.000 description 2
241000282412 Homo Species 0.000 description 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
239000004367 Lipase Substances 0.000 description 2
108090001060 Lipase Proteins 0.000 description 2
102000004882 Lipase Human genes 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 2
241000204031 Mycoplasma Species 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
206010046914 Vaginal infection Diseases 0.000 description 2
238000002835 absorbance Methods 0.000 description 2
239000002253 acid Substances 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
239000004480 active ingredient Substances 0.000 description 2
230000000996 additive effect Effects 0.000 description 2
125000001931 aliphatic group Chemical group 0.000 description 2
125000003342 alkenyl group Chemical group 0.000 description 2
150000001408 amides Chemical class 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
230000001147 anti-toxic effect Effects 0.000 description 2
230000003115 biocidal effect Effects 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
239000010839 body fluid Substances 0.000 description 2
210000004556 brain Anatomy 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
210000003756 cervix mucus Anatomy 0.000 description 2
239000013043 chemical agent Substances 0.000 description 2
239000007979 citrate buffer Substances 0.000 description 2
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
235000014113 dietary fatty acids Nutrition 0.000 description 2
ILRSCQWREDREME-UHFFFAOYSA-N dodecanamide Chemical compound CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 description 2
239000003937 drug carrier Substances 0.000 description 2
239000003974 emollient agent Substances 0.000 description 2
231100000655 enterotoxin Toxicity 0.000 description 2
230000002255 enzymatic effect Effects 0.000 description 2
229920001249 ethyl cellulose Polymers 0.000 description 2
235000019325 ethyl cellulose Nutrition 0.000 description 2
239000000194 fatty acid Substances 0.000 description 2
229930195729 fatty acid Natural products 0.000 description 2
150000004665 fatty acids Chemical class 0.000 description 2
239000010408 film Substances 0.000 description 2
229920001821 foam rubber Polymers 0.000 description 2
210000005224 forefinger Anatomy 0.000 description 2
238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
239000000499 gel Substances 0.000 description 2
MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 2
238000001802 infusion Methods 0.000 description 2
230000002147 killing effect Effects 0.000 description 2
239000002655 kraft paper Substances 0.000 description 2
235000019421 lipase Nutrition 0.000 description 2
238000004811 liquid chromatography Methods 0.000 description 2
230000005923 long-lasting effect Effects 0.000 description 2
239000006210 lotion Substances 0.000 description 2
229920001684 low density polyethylene Polymers 0.000 description 2
239000004702 low-density polyethylene Substances 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
230000036963 noncompetitive effect Effects 0.000 description 2
239000002736 nonionic surfactant Substances 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
230000027758 ovulation cycle Effects 0.000 description 2
229920009441 perflouroethylene propylene Polymers 0.000 description 2
WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
239000002984 plastic foam Substances 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
229920000098 polyolefin Polymers 0.000 description 2
239000004810 polytetrafluoroethylene Substances 0.000 description 2
229940058401 polytetrafluoroethylene Drugs 0.000 description 2
230000008569 process Effects 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000002904 solvent Substances 0.000 description 2
239000008174 sterile solution Substances 0.000 description 2
239000000829 suppository Substances 0.000 description 2
150000003505 terpenes Chemical class 0.000 description 2
238000011282 treatment Methods 0.000 description 2
239000006150 trypticase soy agar Substances 0.000 description 2
230000002485 urinary effect Effects 0.000 description 2
OQQOAWVKVDAJOI-UHFFFAOYSA-N (2-dodecanoyloxy-3-hydroxypropyl) dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCC OQQOAWVKVDAJOI-UHFFFAOYSA-N 0.000 description 1
DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
PDKAXHLOFWCWIH-UHFFFAOYSA-N 1,1-dichlorobuta-1,3-diene Chemical compound ClC(Cl)=CC=C PDKAXHLOFWCWIH-UHFFFAOYSA-N 0.000 description 1
GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
GBXRUYNQDDTQQS-UHFFFAOYSA-N 1-O-dodecylglycerol Chemical compound CCCCCCCCCCCCOCC(O)CO GBXRUYNQDDTQQS-UHFFFAOYSA-N 0.000 description 1
CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
QNDGQRJVVZJMJO-UHFFFAOYSA-N 2-(2-undecyl-4,5-dihydroimidazol-1-yl)ethanol Chemical compound CCCCCCCCCCCC1=NCCN1CCO QNDGQRJVVZJMJO-UHFFFAOYSA-N 0.000 description 1
FKMHSNTVILORFA-UHFFFAOYSA-N 2-[2-(2-dodecoxyethoxy)ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCO FKMHSNTVILORFA-UHFFFAOYSA-N 0.000 description 1
ALOVPZWOOLXQEU-UHFFFAOYSA-N 2-[2-dodecoxyethyl(2-hydroxyethyl)amino]ethanol;sulfuric acid Chemical group OS(O)(=O)=O.CCCCCCCCCCCCOCCN(CCO)CCO ALOVPZWOOLXQEU-UHFFFAOYSA-N 0.000 description 1
LJWSDBHOEIBWJY-UHFFFAOYSA-N 2-benzamido-3-sulfanylpropanoic acid Chemical compound OC(=O)C(CS)NC(=O)C1=CC=CC=C1 LJWSDBHOEIBWJY-UHFFFAOYSA-N 0.000 description 1
AEDQNOLIADXSBB-UHFFFAOYSA-N 3-(dodecylazaniumyl)propanoate Chemical compound CCCCCCCCCCCCNCCC(O)=O AEDQNOLIADXSBB-UHFFFAOYSA-N 0.000 description 1
108010077805 Bacterial Proteins Proteins 0.000 description 1
241000606125 Bacteroides Species 0.000 description 1
241000222122 Candida albicans Species 0.000 description 1
239000004215 Carbon black (E152) Substances 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
229920000298 Cellophane Polymers 0.000 description 1
241000606161 Chlamydia Species 0.000 description 1
241000606153 Chlamydia trachomatis Species 0.000 description 1
241000186216 Corynebacterium Species 0.000 description 1
229920000858 Cyclodextrin Polymers 0.000 description 1
229920001353 Dextrin Polymers 0.000 description 1
239000004375 Dextrin Substances 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
208000010201 Exanthema Diseases 0.000 description 1
BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
241000207201 Gardnerella vaginalis Species 0.000 description 1
208000009889 Herpes Simplex Diseases 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
244000062730 Melissa officinalis Species 0.000 description 1
235000010654 Melissa officinalis Nutrition 0.000 description 1
208000034486 Multi-organ failure Diseases 0.000 description 1
208000010718 Multiple Organ Failure Diseases 0.000 description 1
241000204048 Mycoplasma hominis Species 0.000 description 1
QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 1
241000206591 Peptococcus Species 0.000 description 1
229920012485 Plasticized Polyvinyl chloride Polymers 0.000 description 1
229920001328 Polyvinylidene chloride Polymers 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
206010037660 Pyrexia Diseases 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
241000191940 Staphylococcus Species 0.000 description 1
241000191967 Staphylococcus aureus Species 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
241000194017 Streptococcus Species 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
101710101607 Toxic shock syndrome toxin-1 Proteins 0.000 description 1
241000224527 Trichomonas vaginalis Species 0.000 description 1
241000202898 Ureaplasma Species 0.000 description 1
201000008100 Vaginitis Diseases 0.000 description 1
229920006387 Vinylite Polymers 0.000 description 1
241000700605 Viruses Species 0.000 description 1
206010047700 Vomiting Diseases 0.000 description 1
230000003187 abdominal effect Effects 0.000 description 1
238000005299 abrasion Methods 0.000 description 1
230000009471 action Effects 0.000 description 1
239000011149 active material Substances 0.000 description 1
239000013543 active substance Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
241001148470 aerobic bacillus Species 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
150000003973 alkyl amines Chemical class 0.000 description 1
150000005215 alkyl ethers Chemical class 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
238000000540 analysis of variance Methods 0.000 description 1
229960004543 anhydrous citric acid Drugs 0.000 description 1
125000000129 anionic group Chemical group 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
230000001139 anti-pruritic effect Effects 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
239000003096 antiparasitic agent Substances 0.000 description 1
229940125687 antiparasitic agent Drugs 0.000 description 1
239000003908 antipruritic agent Substances 0.000 description 1
239000003443 antiviral agent Substances 0.000 description 1
229940121357 antivirals Drugs 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
150000008378 aryl ethers Chemical class 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
239000003212 astringent agent Substances 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
OHDRQQURAXLVGJ-UHFFFAOYSA-N azane;3-ethyl-2-[(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C1=NN=C1SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-UHFFFAOYSA-N 0.000 description 1
239000003899 bactericide agent Substances 0.000 description 1
230000002368 bacteriocinic effect Effects 0.000 description 1
238000005452 bending Methods 0.000 description 1
230000002599 biostatic effect Effects 0.000 description 1
239000010836 blood and blood product Substances 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
229940125691 blood product Drugs 0.000 description 1
210000003103 bodily secretion Anatomy 0.000 description 1
229940095731 candida albicans Drugs 0.000 description 1
239000002775 capsule Substances 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
125000002843 carboxylic acid group Chemical group 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002301 cellulose acetate Polymers 0.000 description 1
229920003086 cellulose ether Polymers 0.000 description 1
230000008859 change Effects 0.000 description 1
229940038705 chlamydia trachomatis Drugs 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
239000004927 clay Substances 0.000 description 1
238000002648 combination therapy Methods 0.000 description 1
239000002131 composite material Substances 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
239000013068 control sample Substances 0.000 description 1
239000002537 cosmetic Substances 0.000 description 1
238000005336 cracking Methods 0.000 description 1
239000006071 cream Substances 0.000 description 1
229940097362 cyclodextrins Drugs 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
235000019425 dextrin Nutrition 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
229940061607 dibasic sodium phosphate Drugs 0.000 description 1
VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical compound [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 1
150000005690 diesters Chemical class 0.000 description 1
KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
229940079881 disodium lauroamphodiacetate Drugs 0.000 description 1
QKQCPXJIOJLHAL-UHFFFAOYSA-L disodium;2-[2-(carboxylatomethoxy)ethyl-[2-(dodecanoylamino)ethyl]amino]acetate Chemical compound [Na+].[Na+].CCCCCCCCCCCC(=O)NCCN(CC([O-])=O)CCOCC([O-])=O QKQCPXJIOJLHAL-UHFFFAOYSA-L 0.000 description 1
JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
239000000147 enterotoxin Substances 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
230000008029 eradication Effects 0.000 description 1
125000004185 ester group Chemical group 0.000 description 1
HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
125000001033 ether group Chemical group 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
UKFXDFUAPNAMPJ-UHFFFAOYSA-N ethylmalonic acid Chemical compound CCC(C(O)=O)C(O)=O UKFXDFUAPNAMPJ-UHFFFAOYSA-N 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
201000005884 exanthem Diseases 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
239000002095 exotoxin Substances 0.000 description 1
231100000776 exotoxin Toxicity 0.000 description 1
238000013401 experimental design Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000000416 exudates and transudate Anatomy 0.000 description 1
238000011010 flushing procedure Methods 0.000 description 1
239000006260 foam Substances 0.000 description 1
239000011888 foil Substances 0.000 description 1
239000003292 glue Substances 0.000 description 1
229940074049 glyceryl dilaurate Drugs 0.000 description 1
229940068939 glyceryl monolaurate Drugs 0.000 description 1
230000036541 health Effects 0.000 description 1
150000004687 hexahydrates Chemical class 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
238000007654 immersion Methods 0.000 description 1
238000005470 impregnation Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000009545 invasion Effects 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
229940116335 lauramide Drugs 0.000 description 1
229940057905 laureth-3 Drugs 0.000 description 1
LAPRIVJANDLWOK-UHFFFAOYSA-N laureth-5 Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCO LAPRIVJANDLWOK-UHFFFAOYSA-N 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
239000000865 liniment Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
229960005015 local anesthetics Drugs 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
230000001050 lubricating effect Effects 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
238000002483 medication Methods 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000009247 menarche Effects 0.000 description 1
230000009245 menopause Effects 0.000 description 1
230000005906 menstruation Effects 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
244000000010 microbial pathogen Species 0.000 description 1
239000013586 microbial product Substances 0.000 description 1
210000004877 mucosa Anatomy 0.000 description 1
208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
TWMFGCHRALXDAR-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]dodecanamide Chemical compound CCCCCCCCCCCC(=O)NCCCN(C)C TWMFGCHRALXDAR-UHFFFAOYSA-N 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
239000004745 nonwoven fabric Substances 0.000 description 1
LYRFLYHAGKPMFH-UHFFFAOYSA-N octadecanamide Chemical class CCCCCCCCCCCCCCCCCC(N)=O LYRFLYHAGKPMFH-UHFFFAOYSA-N 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
AHKZTVQIVOEVFO-UHFFFAOYSA-N oxide(2-) Chemical compound [O-2] AHKZTVQIVOEVFO-UHFFFAOYSA-N 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
150000002978 peroxides Chemical class 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
229920001084 poly(chloroprene) Polymers 0.000 description 1
229920002635 polyurethane Polymers 0.000 description 1
239000004814 polyurethane Substances 0.000 description 1
239000005033 polyvinylidene chloride Substances 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
206010037844 rash Diseases 0.000 description 1
230000009467 reduction Effects 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
238000000926 separation method Methods 0.000 description 1
230000001568 sexual effect Effects 0.000 description 1
WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
239000004299 sodium benzoate Substances 0.000 description 1
235000010234 sodium benzoate Nutrition 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
229940057950 sodium laureth sulfate Drugs 0.000 description 1
229940079862 sodium lauryl sarcosinate Drugs 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 1
LLKGTXLYJMUQJX-UHFFFAOYSA-M sodium;3-[2-carboxyethyl(dodecyl)amino]propanoate Chemical compound [Na+].CCCCCCCCCCCCN(CCC(O)=O)CCC([O-])=O LLKGTXLYJMUQJX-UHFFFAOYSA-M 0.000 description 1
210000005070 sphincter Anatomy 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000005846 sugar alcohols Polymers 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
150000008054 sulfonate salts Chemical group 0.000 description 1
125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
229920002994 synthetic fiber Polymers 0.000 description 1
239000012209 synthetic fiber Substances 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
235000007586 terpenes Nutrition 0.000 description 1
238000010998 test method Methods 0.000 description 1
238000012549 training Methods 0.000 description 1
238000012546 transfer Methods 0.000 description 1
241001148471 unidentified anaerobic bacterium Species 0.000 description 1
210000003708 urethra Anatomy 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
230000008673 vomiting Effects 0.000 description 1
238000003260 vortexing Methods 0.000 description 1
229920003176 water-insoluble polymer Polymers 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
- A61L2300/214—Amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/432—Inhibitors, antagonists
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- A61L2300/604—Biodegradation

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Hematology (AREA)
Materials Engineering (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
Absorbent Articles And Supports Therefor (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AU2005292655A 2004-09-30 2005-08-10 Non-absorbent and absorbent articles for inhibiting the production of exoproteins Withdrawn AU2005292655A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US10/955,821 US20060067990A1 (en)	2004-09-30	2004-09-30	Absorbent articles for inhibiting the production of exoproteins
US10/955,858 US20060067991A1 (en)	2004-09-30	2004-09-30	Non-absorbent articles for inhibiting the production of exoproteins
US10/955,821		2004-09-30
US10/955,858		2004-09-30
PCT/US2005/028366 WO2006038980A2 (fr)	2004-09-30	2005-08-10	Articles non absorbants et absorbants inhibant la production d'exoproteines

Publications (1)

Publication Number	Publication Date
AU2005292655A1 true AU2005292655A1 (en)	2006-04-13

Family

ID=36066376

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2005292655A Withdrawn AU2005292655A1 (en)	2004-09-30	2005-08-10	Non-absorbent and absorbent articles for inhibiting the production of exoproteins

Country Status (8)

Country	Link
EP (1)	EP1793871A2 (fr)
JP (1)	JP2008514698A (fr)
KR (1)	KR20070057884A (fr)
AU (1)	AU2005292655A1 (fr)
BR (1)	BRPI0515949A (fr)
IL (1)	IL181198A0 (fr)
RU (1)	RU2007111692A (fr)
WO (1)	WO2006038980A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20100130907A1 (en) *	2008-11-21	2010-05-27	Linkel Stephan M	Article of manufacture used in contact with human body surfaces

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE524930A (fr) *	1952-12-09
GB830139A (en) *	1954-12-29	1960-03-09	George Van Norden Morin	Fabrics containing bactericidal agents
US3027301A (en) *	1959-03-16	1962-03-27	Us Vitamin Pharm Corp	Therapeutic wound healing composition of hydroxypropylamides of hydroxybenzoic acids
US4431427A (en) *	1981-10-05	1984-02-14	University Of Delaware	Tampons and their manufacture
US4725590A (en) *	1983-08-24	1988-02-16	Lever Brothers Company	Method of relieving pain and inflammatory conditions employing substituted salicylamides
US5663357A (en) *	1995-11-22	1997-09-02	Allergan	Substituted heteroarylamides having retinoid-like biological activity
US6676957B1 (en) *	2000-11-28	2004-01-13	Kimberly-Clark Worldwide, Inc.	Non-absorbent substrates for the inhibition of exoprotein production from gram positive bacteria
US7691403B2 (en) *	2001-11-21	2010-04-06	Kimberly-Clark Worldwide, Inc.	Non-absorbent tampon containing additives inhibiting TSST-1

2005
- 2005-08-10 JP JP2007534582A patent/JP2008514698A/ja not_active Abandoned
- 2005-08-10 EP EP05785615A patent/EP1793871A2/fr not_active Withdrawn
- 2005-08-10 RU RU2007111692/15A patent/RU2007111692A/ru not_active Application Discontinuation
- 2005-08-10 AU AU2005292655A patent/AU2005292655A1/en not_active Withdrawn
- 2005-08-10 WO PCT/US2005/028366 patent/WO2006038980A2/fr not_active Ceased
- 2005-08-10 KR KR1020077007186A patent/KR20070057884A/ko not_active Withdrawn
- 2005-08-10 BR BRPI0515949-0A patent/BRPI0515949A/pt not_active IP Right Cessation
2007
- 2007-02-07 IL IL181198A patent/IL181198A0/en unknown

Also Published As

Publication number	Publication date
RU2007111692A (ru)	2008-11-10
EP1793871A2 (fr)	2007-06-13
KR20070057884A (ko)	2007-06-07
WO2006038980A2 (fr)	2006-04-13
BRPI0515949A (pt)	2008-08-12
IL181198A0 (en)	2007-07-04
JP2008514698A (ja)	2008-05-08
WO2006038980A3 (fr)	2006-06-29

Publication	Publication Date	Title
US5612045A (en)	1997-03-18	Inhibition of exoprotein in absorbent article
CA2221507C (fr)	2008-01-15	Inhibition d'exoproteines dans un article absorbant
ZA200402226B (en)	2006-05-31	Inhibition of exoproteins using isoprenoids
US6821999B2 (en)	2004-11-23	Methods for inhibiting the production of TSST-1
US20080096850A1 (en)	2008-04-24	Methods for inhibiting the production of tsst-1
US7118759B2 (en)	2006-10-10	Absorbent articles containing additives
AU2005292655A1 (en)	2006-04-13	Non-absorbent and absorbent articles for inhibiting the production of exoproteins
US20060067991A1 (en)	2006-03-30	Non-absorbent articles for inhibiting the production of exoproteins
US20060067990A1 (en)	2006-03-30	Absorbent articles for inhibiting the production of exoproteins
AU2002336472B2 (en)	2007-08-23	Inhibition of exoprotein production using aromatic compositions
US20080033382A1 (en)	2008-02-07	Inhibition of exoprotein production in absorbent articles using aromatic compositions
MX2007003706A (en)	2008-10-03	Non-absorbent and absorbent articles for inhibiting the production of exoproteins
US20040266887A1 (en)	2004-12-30	Inhibition of exoprotein production using aromatic compositions in non-absorbent articles
ZA200402228B (en)	2006-05-31	Inhibition of exoprotein production using aromatic compositions
US8084046B2 (en)	2011-12-27	Inhibition of exoprotein production in absorbent articles using isoprenoids
AU2002336472A1 (en)	2003-07-03	Inhibition of exoprotein production using aromatic compositions
AU2002326861B2 (en)	2007-03-08	Inhibition of exoproteins using isoprenoids
US7348023B2 (en)	2008-03-25	Absorbent articles containing additives
EP1432458A1 (fr)	2004-06-30	Inhibition des exoproteines au moyen d'isoprenoides
AU2002326861A1 (en)	2003-06-26	Inhibition of exoproteins using isoprenoids

Legal Events

Date	Code	Title	Description
2009-07-23	MK12	Application lapsed section 141(1)/reg 8.3(2) - applicant filed a written notice of withdrawal